Favorable long term effects of intensified immunosuppression combined with therapeutic plasma exchange in patients with early-onset progressive systemic sclerosis-related interstitial lung disease.

Potjewijd, J; Tobal, R; Silvertand, D; Gietema, H A; Damoiseaux, J G M C; van Paassen, P

Potjewijd, J; Tobal, R; Silvertand, D; Gietema, H A; Damoiseaux, J G M C; van Paassen, P.

Afiliação

Potjewijd J; Department of Internal Medicine, Division Nephrology and Clinical Immunology, Maastricht University Medical Center, Maastricht, the Netherlands.
Tobal R; Department of Internal Medicine, Division Nephrology and Clinical Immunology, Maastricht University Medical Center, Maastricht, the Netherlands.
Silvertand D; Department of Internal Medicine, Division Nephrology and Clinical Immunology, Maastricht University Medical Center, Maastricht, the Netherlands.
Gietema HA; Department of Radiology and Nuclear Medicine, Maastricht University Medical Center, Maastricht, the Netherlands.
Damoiseaux JGMC; Diagnostic Laboratory, Maastricht University Medical Center, Maastricht, the Netherlands.
van Paassen P; Department of Internal Medicine, Division Nephrology and Clinical Immunology, Maastricht University Medical Center, Maastricht, the Netherlands.

J Transl Autoimmun ; 5: 100174, 2022.

Article em En | MEDLINE | ID: mdl-36458101

Palavras-chave

EFS, Event Free Survival; EOc, Estimated Optimal care; ILD, Interstitial lung disease; PAH, Pulmonary Arterial Hypertension; SMR, Standardized Mortality rate; SSc, Systemic Sclerosis; TPE, Therapeutic Plasma Exchange

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Prognostic_studies Idioma: En Revista: J Transl Autoimmun Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Holanda País de publicação: Holanda

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google